Back Pain Doctor
Ankle Osteoarthritis (Ankle Arthritis)
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
The ankle joint is formed where the shin bone meets the talus, the bone that sits beneath it. It is built to hinge the foot up and down, and when its cartilage wears, the joint becomes stiff, achy and sometimes swollen. It is far less common than knee or hip arthritis, and the story is different. Most ankle arthritis follows an injury, so a past fracture, a serious sprain or years of the ankle giving way is the most useful clue.
Assessment starts with that history, then examines the shape and movement of the ankle and which part of the foot is really painful, because tendon, nerve and neighbouring joint problems can feel similar. Weight-bearing x-rays are the usual first test. Some situations need prompt review rather than waiting, including a hot, red, swollen ankle with fever, a sudden swollen ankle with no injury, severe pain after a fall, and pain at night or at rest that does not ease.
Care begins with the basics: simple pain relief, a supportive or rocker-soled shoe, a brace or walking stick if it helps, strengthening and movement work with a physiotherapist, and weight management where relevant. There are no ankle-specific guidelines, and most of the evidence for these measures comes from knee and hip arthritis, so the aim is to try them and see what helps you. Injections have limited support at this joint, and we say so plainly. If pain stays severe despite a proper trial of non-surgical care, referral to an orthopaedic foot and ankle surgeon is the next step.
Common symptoms
- Aching pain in the ankle that is worse with walking, stairs and uneven ground
- Stiffness, especially after rest, and less ability to bend the foot up
- Swelling or a bony thickening around the ankle joint
- A past ankle fracture, serious sprain or an ankle that has often given way
Commonly seen in
Evidence for twelve treatment options in ankle osteoarthritis (ankle arthritis)
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation — diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Knee and hip evidence only
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan — with weight management where that is clinically relevant.
What the evidence shows
Exercise, education and weight management are the standard first-line care for osteoarthritis, but the trial evidence is in the knee and hip, not the ankle. In knee and hip osteoarthritis a network meta-analysis of 152 randomised trials found exercise gave similar pain relief and function to oral anti-inflammatories and paracetamol (Weng, Br J Sports Med 2023), and EULAR also names footwear, walking aids and weight management in its core recommendations (Moseng, Ann Rheum Dis 2024). At the ankle, a 2015 Cochrane review found no randomised trial of any non-surgical treatment other than hyaluronic acid and warned that hip and knee guidance may not transfer, because ankle arthritis usually follows injury (Cochrane Database Syst Rev 2015). The only ankle exercise study located is a 30-person feasibility trial of education plus exercise against general advice, which showed the trial can be run and did not test whether the programme works (Musculoskelet Sci Pract 2024). A small crossover study of 10 people found no significant difference in pain or function between ordinary shoes, rocker-bottom shoes and an ankle-foot orthosis, with preferences varying by age (Muir, J Prosthet Orthot 2026).
Pairing reviewed 2026-10-04.
Where it fits for you
Still where care starts, because it is safe and the alternatives have thin evidence at this joint, but it is borrowed evidence and we say so. Expect to try footwear, a brace or stick, strengthening and weight management and see what helps your ankle, rather than a programme with a proven ankle result.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with 0.02-0.08% lignocaine is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling — the same technique with nothing injected — is not offered here.
What the evidence shows
No study has tested needling in ankle osteoarthritis. A PubMed search pairing ankle, tibiotalar and talocrural with arthritis or osteoarthritis and dry needling, trigger point, wet needling, acupuncture and electroacupuncture returned 59 records. On screening the titles, nearly all were animal or acupoint laboratory studies, rheumatoid arthritis, acute injury or other joints, and the only human ankle osteoarthritis item was a 2026 randomised trial protocol of electroacupuncture combined with diclofenac gel, which reports no results (J Pain Res 2026).
Pairing reviewed 2026-10-04.
Where it fits for you
Only where a separate tender band in the calf or foot muscles is reproducing part of the pain. It does not treat the worn joint.
Ultrasound-guided injections Guidance means we can see the needle reach the target. What goes into the needle depends on the diagnosis. Weak evidence for any injectate
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis — and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
Guidance and injectate answer different questions here. Ultrasound reliably places a needle inside the ankle joint, with 100 per cent accuracy in cadaver work (Reach, Foot Ankle Int 2009). One cadaver study found blind injection into the ankle joint was also 100 per cent accurate, and that guidance mattered for the midfoot joints rather than the ankle (Khosla, Foot Ankle Int 2009). A 2026 systematic review of five tibiotalar studies concluded ultrasound was more accurate than landmark injection, and one randomised trial in inflamed joints found better pain control at six weeks, but it found no high-quality trials of outcomes (Gharib, Arch ISPRM 2026). What goes in the joint has weak support. A 2025 systematic review found only two small randomised trials of corticosteroid in foot and ankle osteoarthritis and none against placebo at the ankle (Rheumatol Adv Pract 2025). One trial of 135 people found corticosteroid plus hyaluronic acid beat corticosteroid alone on ankle scores at 6 and 12 weeks, but pain was lower with corticosteroid alone at 6 weeks and the same at 12 (Woo, BMC Musculoskelet Disord 2025). Trials of hyaluronic acid and platelet-rich plasma against saline are mostly negative (see their rows).
Pairing reviewed 2026-10-04.
Where it fits for you
An option to settle a flare enough to get walking, footwear and exercise started, not a treatment of the arthritis and not something to repeat on a schedule. Ultrasound is used for accuracy, but the ankle joint can usually be entered without it.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Only if relevant
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No clinical study of vibration or percussive devices in ankle osteoarthritis. A PubMed search pairing ankle, tibiotalar and talocrural with arthritis or osteoarthritis and vibration or percussion returned nine records; none studied the ankle joint, and they covered whole-body vibration in knee osteoarthritis, elderly balance and occupational risk.
Pairing reviewed 2026-10-04.
Where it fits for you
A comfort measure within a session, only where tight calf or foot muscles are limiting movement. Not a treatment for the arthritic joint.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Plausible — no studies
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue — including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
No randomised trial of shockwave in ankle osteoarthritis. A PubMed search pairing ankle, tibiotalar and talocrural with arthritis or osteoarthritis and shockwave terms returned one record, a technique video on the big toe joint, and a second search for radial or focused shockwave in ankle osteoarthritis returned only unrelated items. The osteoarthritis evidence is in the knee, where a meta-analysis of 12 randomised trials favoured shockwave over sham for pain and function in the short term, with high heterogeneity (Silva, Clin Rehabil 2023).
Pairing reviewed 2026-10-04.
Where it fits for you
Reasonable to discuss on the same mechanism, with the gap stated. It is not a substitute for footwear, walking aids, exercise and weight management.
Focused shockwave (ESWT) A true shock wave converging at depth — for tendon, joint, ligament and bone. Plausible — no studies
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form we use for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
No randomised trial has tested shockwave for ankle osteoarthritis: searching ankle osteoarthritis and ankle arthritis against shockwave, shock wave and ESWT returns no study of either device. The nearest evidence at this joint is in cartilage injury of the talus rather than arthritis. Fifteen people with persisting pain after keyhole surgery for an osteochondral lesion improved in pain and ankle scores twelve weeks after shockwave, with smaller lesions on MRI at follow-up (Zhang, J Foot Ankle Surg 2020), and in a retrospective comparison, shockwave after microfracture gave better ankle scores at two years than platelet-rich plasma after microfracture (Li, J Clin Med 2023). The osteoarthritis trials themselves are at the knee and hip (Tang, Int J Surg 2024; Şah, J Pers Med 2022).
Pairing reviewed 2026-10-04.
Where it fits for you
A reasonable option to try for arthritic ankle pain on the strength of the knee and hip trials, with the gap at this joint stated plainly. Used alongside footwear, bracing where it helps, exercise and weight management.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Painless, no contact. Plausible — no studies
What it involves
You sit with the applicator positioned over the area for a short session. Painless, no gel or contact required, and usually delivered as a course — commonly alongside shockwave.
What the evidence shows
No trial of electromagnetic transduction therapy in ankle osteoarthritis. The nearest human evidence is an uncontrolled pilot of eight people with midfoot osteoarthritis, in which pain scores fell over time overall but the comparisons with baseline at three and six months did not reach statistical significance, function scores improved, and there was no sham group (J Am Podiatr Med Assoc 2026). For the related pulsed electromagnetic field therapy, the evidence is in knee osteoarthritis. A PubMed search of ankle and tibiotalar osteoarthritis with electromagnetic terms returned seven records, none a human ankle osteoarthritis trial.
Pairing reviewed 2026-10-04.
Where it fits for you
Offered only as an adjunct alongside care that has evidence, never as the plan itself, and only after the gap is explained. Much of the published work is manufacturer-linked, which is part of why we say so.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. One trial, no benefit over saline
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
The only placebo-controlled trial found no benefit. In 100 people with ankle osteoarthritis given two PRP or two saline injections six weeks apart, the adjusted difference in AOFAS score over 52 weeks was 2 points in favour of saline (95% CI -5 to 2) and no secondary outcome differed (Paget, Am J Sports Med 2023). A systematic review of the ankle injection trials found no clinically relevant difference from placebo at 3, 6 or 12 months, with the PRP evidence graded moderate certainty and resting on that single trial (Paget, Clin Orthop Relat Res 2023). Evidence outside controlled trials is more favourable but weaker. A meta-analysis of four studies in 127 people (three cohorts and one randomised trial) found AOFAS and pain improvements at six months or longer that reached the minimal clinically important difference, though short-term gains did not and heterogeneity was high (Int Orthop 2023). Another pooled before-and-after data and noted the improvement was about the size of the placebo response in the trial (J Orthop Surg Res 2023). A single-centre retrospective series of 178 people reported pain falling from 6.6 to 2.4 out of 10 at six months, held to 36 months, with the best results in milder disease and in athletes, and no control group (BMC Musculoskelet Disord 2026). Across foot and ankle conditions, PRP was followed by more treatment-site pain than comparison injections (odds ratio 2.23, number needed to harm 13), with serious complications rare (Arthroscopy 2025).
Pairing reviewed 2026-10-04.
Where it fits for you
Offered as an option for people who want to try an injection after footwear, bracing, strengthening and weight management, and particularly considered for younger or athletic people with milder joint wear, where the uncontrolled results were best. The expectation set up front is a possible benefit rather than a likely one, because the one saline-controlled trial found no advantage; it can leave the ankle more sore for a few days, and it is not expected to restore worn cartilage. Response is reviewed at six to twelve weeks and it is not repeated if there has been no benefit.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Plausible — no studies
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No trial of dextrose prolotherapy in ankle osteoarthritis. A PubMed search pairing ankle, tibiotalar and talocrural with arthritis or osteoarthritis and prolotherapy or dextrose returned seven records. They were a trial protocol and a randomised trial in chronic ankle instability, a retrospective comparison with PRP in talar cartilage lesions, a case series of seven people with hip, knee or ankle osteoarthritis who received bone marrow plus dextrose, and two systematic reviews of injections. In chronic ankle instability, a 114-person placebo-controlled trial found dextrose improved balance and re-sprains but not its primary instability score (Arch Phys Med Rehabil 2026), and a smaller trial in chronic ligament sprain found no pain benefit over saline (Arch Phys Med Rehabil 2026). The osteoarthritis evidence is in the knee, where a meta-analysis of 14 trials favoured dextrose, with caution about heterogeneity and bias (Chen, Clin Rehabil 2022).
Pairing reviewed 2026-10-04.
Where it fits for you
Reasonable to discuss on the same rationale, with the gap in evidence stated. It would not replace footwear, walking aids and exercise, and it does not treat an arthritic joint that has lost its cartilage.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Low certainty, mostly negative
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Ankle trials exist and they disagree. A 2015 Cochrane review pooled two of three small placebo-controlled hyaluronic acid trials and found a possible benefit at six months on the Ankle Osteoarthritis Scale (12 points on a 100-point scale, 45 people), graded low quality, and concluded hyaluronic acid could be conditionally recommended if simple analgesics fail (Cochrane Database Syst Rev 2015). A 2020 meta-analysis favoured hyaluronic acid over saline at six months at very low certainty (Int Orthop 2020). Later work is more negative. A systematic review of seven trials found no clinically relevant difference from placebo at 3, 6 or 12 months and advised against using these injections in practice until better trials exist (Paget, Clin Orthop Relat Res 2023). A 2025 meta-analysis of six trials in 274 people found no significant difference in pain, AOFAS or ankle scores, with limited benefit (Tham, Foot Ankle Spec 2025). A placebo-controlled trial of a diclofenac-hyaluronate product in 60 people found no ankle benefit although it helped the hip (Kubo, BMC Musculoskelet Disord 2022).
Pairing reviewed 2026-10-04.
Where it fits for you
A low-certainty option that may be discussed for a person who wants an injection and has not responded to simpler measures, with the mostly negative recent evidence stated. It would not be expected to change the arthritis.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve—not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Only if relevant
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
No study has injected dextrose or other solution around skin nerves for ankle osteoarthritis. A PubMed search pairing ankle, tibiotalar and talocrural with arthritis or osteoarthritis and perineural, hydrodissection, nerve block, neurolysis or radiofrequency returned 20 records, mostly operative anaesthesia and nerve complications of ankle replacement, none a perineural injection for the arthritic joint.
Pairing reviewed 2026-10-04.
Where it fits for you
Only if a separate tender, hypersensitive nerve territory is found around the ankle, for example after an old fracture or scar. Pain from inside the joint is not what this treats.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
No study has tested hydrodissection for ankle osteoarthritis. The same 20-record search for ankle osteoarthritis with hydrodissection or perineural terms found none for the arthritic joint. Where the technique does appear in this region it is for a different problem, a case report of freeing the sural nerve from scar after a heel bone fracture (Cureus 2025).
Pairing reviewed 2026-10-04.
Where it fits for you
Only where examination suggests a nerve trapped in scar after an old injury. It does not treat the worn joint surface.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments we do not offer, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So we do not build treatment plans around it. Where an injection is the right call, we review the specific diagnosis and target, discuss what is being injected and why, keep the number low, and pair it with the loading work that changes the longer-term course.
When we would still consider it
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal — a trip, a procedure, a return to work
- Diagnostic use, where the response tells us where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other foot, ankle & lower leg conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
Why do I have arthritis in my ankle?
Do injections help ankle arthritis?
When is surgery considered?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
Book an appointment